Search Results

Displaying Results 9326-9350 of 10412 "'ID'"

Jul 30, 2025, 07:00 ET Resideo Signs Agreement To Accelerate Payment of All Potential Monetary Obligations Under Indemnification and Reimbursement Agreement with Honeywell and Eliminate All Future Payments

following the presentation. To join the conference call, please dial (800) 715-9871 (U.S. toll-free) or (646) 307-1963 (international) with the conference ID: 4230758. Advisors Willkie Farr & Gallagher LLP is serving as legal counsel to Resideo and Collected

More news about: Resideo Technologies, Inc.


Jul 30, 2025, 06:30 ET Entergy reports second quarter 2025 financial results

investors.entergy.com/investors/events-and-presentations or by dialing 888-440-4149, conference ID 9024832, no more than 15 minutes prior to the start of the call. The webcast presentation is also being posted to Entergy's website concurrent with this

More news about: Entergy Corporation


Jul 30, 2025, 06:30 ET CGI reports third quarter Fiscal 2025 results

morning at 9:00 a.m. (EDT) to discuss results. Participants may access the call by dialing +1-800-717-1738 Conference ID: 28135 or via

More news about: CGI Inc.


Jul 30, 2025, 06:00 ET Clarivate Reports Second Quarter 2025 Results

broadcast. U.S. participants may call 800-715-9871; international participants may call +1 646-307-1963 (long-distance charges will apply). The conference ID number is 7007526. A replay of the webcast will also be available on

More news about: Clarivate Plc


Jul 30, 2025, 06:00 ET Clarivate Reports Second Quarter 2025 Results

broadcast. U.S. participants may call 800-715-9871; international participants may call +1 646-307-1963 (long-distance charges will apply). The conference ID number is 7007526. A replay of the webcast will also be available on

More news about: Clarivate Plc


Jul 30, 2025, 05:00 ET Calling All Explorers for New "Jurassic World: Rebirth" AI-Immersive Experience with Prezzee

collect, holds the key to a drug that will bring miraculous life-saving benefits to humankind. After receiving a personalized mission briefing and ID card, those explorers that are fearless enough can join this thrilling mission, and also have the chance to win a $1,000

More news about: Prezzee


Jul 30, 2025, 04:06 ET WAIC 2025: Shanghai Electric Lansir Robot Humanoid Industri Perdana, "SUYUAN", Memajukan Manufaktur Pintar Generasi Baru Lewat Rencana Pengembangan Rantai Nilai Industri yang Holistis

multimedia:https://www.prnewswire.com/id/rilis-berita/waic-2025-shanghai-electric-lansir-robot-humanoid-industri-perdana-suyuan-memajukan-manufaktur-pintar-generasi-baru-lewat-rencana-pengembangan-rantai-nilai-industri-yang-holistis-302517128.html

More news about: Shanghai Electric


Jul 30, 2025, 04:00 ET Cetak Biru Bisnis Kosmetika: Melalui Pameran Interaktif, Meiyume Indonesia Memaparkan Cara Bagaimana Mewujudkan Inovasi Berdasarkan Analisis Pasar

multimedia:https://www.prnewswire.com/id/rilis-berita/cetak-biru-bisnis-kosmetika-melalui-pameran-interaktif-meiyume-indonesia-memaparkan-cara-bagaimana-mewujudkan-inovasi-berdasarkan-analisis-pasar-302517119.html

More news about: Meiyume


Jul 29, 2025, 23:06 ET Beijing Review: Bridge of Hearts

https://www.tiktok.com/@cachinachic/video/7530832135125470494?is_from_webapp=1&sender_device=pc&web_id=7227134149436605995

More news about: Beijing Review


Jul 29, 2025, 22:00 ET Hydroleap Raih Investasi USD 4,75 Juta dalam Babak Pendanaan Terbaru guna Mempercepat Perkembangan Teknologi Pengolahan Air yang Berkelanjutan di Asia Pasifik

multimedia:https://www.prnewswire.com/id/rilis-berita/hydroleap-raih-investasi-usd-4-75-juta-dalam-babak-pendanaan-terbaru-guna-mempercepat-perkembangan-teknologi-pengolahan-air-yang-berkelanjutan-di-asia-pasifik-302513736.html

More news about: Hydroleap Pte Ltd


Jul 29, 2025, 20:43 ET Bedah Ortopedi Presisi di Asia: Memenuhi Kebutuhan Regional Lewat Kolaborasi Akademik bersama MOA dan Aclub

multimedia:https://www.prnewswire.com/id/rilis-berita/bedah-ortopedi-presisi-di-asia-memenuhi-kebutuhan-regional-lewat-kolaborasi-akademik-bersama-moa-dan-aclub-302516763.html

More news about: A PLUS BIOTECHNOLOGY CORPORATION LIMITED


Jul 29, 2025, 19:21 ET Rosen Law Firm Encourages Designer Brands Inc. Investors to Inquire About Securities Class Action Investigation - DBI

https://rosenlegal.com/submit-form/?case_id=40581 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email

More news about: THE ROSEN LAW FIRM, P. A.


Jul 29, 2025, 17:38 ET ANRO Investors Have Opportunity to Lead Alto Neuroscience, Inc. Securities Fraud Lawsuit

https://rosenlegal.com/submit-form/?case_id=42321 or call Phillip Kim, Esq. at 866-767-3653 or email

More news about: THE ROSEN LAW FIRM, P. A.


Jul 29, 2025, 17:34 ET HIMS Investors Have Opportunity to Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit

https://rosenlegal.com/submit-form/?case_id=40578 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email

More news about: THE ROSEN LAW FIRM, P. A.


Jul 29, 2025, 17:26 ET IRBT Investors Have Opportunity to Lead iRobot Corporation Securities Fraud Lawsuit

https://rosenlegal.com/submit-form/?case_id=23275 or call Phillip Kim, Esq. at 866-767-3653 or email

More news about: THE ROSEN LAW FIRM, P. A.


Jul 29, 2025, 17:23 ET VON DER ALZHEIMER'S ASSOCIATION INTERNATIONAL CONFERENCE 2025: DIE ALZHEIMER'S ASSOCIATION VERÖFFENTLICHT IHRE ERSTE LEITLINIE FÜR DIE KLINISCHE PRAXIS ZU BLUTBASIERTEN BIOMARKERTESTS

Beeinträchtigungen mit Hilfe von blutbasierten Biomarkern und kognitiven Tests: Zwei Leitfadeninitiativen der Alzheimer's Association Proposal ID: 108894Oral Presentation: Dienstag, 29. Juli 2025: 14:00-15:30 UHR EDT (3-21-DEV) Leitfaden für die klinische Praxis für blutbasierte

More news about: Alzheimer's Association


Jul 29, 2025, 17:18 ET LMT Investors Have Opportunity to Lead Lockheed Martin Corporation Securities Fraud Lawsuit

https://rosenlegal.com/submit-form/?case_id=2661 or call Phillip Kim, Esq. at 866-767-3653 or email

More news about: THE ROSEN LAW FIRM, P. A.


Jul 29, 2025, 17:16 ET DEPUIS L'ALZHEIMER'S ASSOCIATION INTERNATIONAL CONFERENCE 2025 : L'ALZHEIMER'S ASSOCIATION PUBLIE SA PREMIÈRE LIGNE DIRECTRICE DE PRATIQUE CLINIQUE POUR LES TESTS DE BIOMARQUEURS SANGUINS

troubles cognitifs à l'aide de biomarqueurs sanguins et de tests cognitifs : Deux initiatives de lignes directrices de l'Alzheimer's Association ID de la proposition : 108894Présentation orale : Mardi 29 juillet 2025 : 14 H 00-15 H 30 EDT (3-21-DEV) Guide de pratique clinique

More news about: Alzheimer's Association


Jul 29, 2025, 17:05 ET BOARDWALK REIT REPORTS STRONG RESULTS FOR Q2 2025

North America). Note: Please provide the operator with the below Conference Call ID or Topic when dialing in to the call. Conference ID: 12767 Topic: Boardwalk Real Estate Investment Trust, 2025 Second Quarter Results Webcast: Investors

More news about: Boardwalk Real Estate Investment Trust


Jul 29, 2025, 17:00 ET FLYW Investors Have Opportunity to Lead Flywire Corporation Securities Fraud Lawsuit

https://rosenlegal.com/submit-form/?case_id=36539 or call Phillip Kim, Esq. at 866-767-3653 or email

More news about: THE ROSEN LAW FIRM, P. A.


Jul 29, 2025, 16:41 ET REPL Investors Have Opportunity to Lead Replimune Group, Inc. Securities Lawsuit First Filed by The Rosen Law Firm

https://rosenlegal.com/submit-form/?case_id=42313 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email

More news about: THE ROSEN LAW FIRM, P. A.


Jul 29, 2025, 16:28 ET Rosen Law Firm Encourages Vera Bradley, Inc. Investors to Inquire About Securities Class Action Investigation - VRA

https://rosenlegal.com/submit-form/?case_id=40454 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email

More news about: THE ROSEN LAW FIRM, P. A.


Jul 29, 2025, 16:05 ET Penumbra, Inc. Reports Second Quarter 2025 Financial Results

at 4:30 PM Eastern Time. The conference call can be accessed live over the phone by dialing (888) 596-4144 (conference id: 6572573), or the webcast can be accessed on the "Events and Presentations" section under the "Investors" tab of the Company's website at:

More news about: Penumbra, Inc.


Jul 29, 2025, 14:36 ET FROM THE ALZHEIMER'S ASSOCIATION INTERNATIONAL CONFERENCE 2025: ALZHEIMER'S ASSOCIATION RELEASES ITS FIRST CLINICAL PRACTICE GUIDELINE FOR BLOOD-BASED BIOMARKER TESTS

Cognitive Impairment using Blood-based Biomarkers and Cognitive Testing: Two Guideline Initiatives from the Alzheimer's Association Proposal ID: 108894Oral Presentation: Tuesday, July 29, 2025: 2:00 P.M.-3:30 P.M. EDT (3-21-DEV) Clinical practice

More news about: Alzheimer's Association


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.